Urszula Kałucka

Ms. Urszula Kałucka

University of Bergen, Bergen, Hordaland, Norway
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Małgorzata MiastkowskaMałgorzata Miastkowska
Małgorzata Miastkowska
TKTomasz Kantyka
Tomasz Kantyka
EBEwa Bielecka
Ewa Bielecka
UKUrszula Kałucka
Urszula Kałucka
MKMarta Kamińska
Marta Kamińska
KCKrzysztof Cudzik
Krzysztof Cudzik
Lavandula angustifolia, one of the most popular medicinal plants, is the source of a bioactive essential oil characterized by a wide spectrum of biological activity, e.g., antiseptic, analgesic, and anticancer effects. In dermatology, the oil helps to relieve skin inflammation and exhibit wound healing potential. However, the mechanism of action of the lavender oil depends on its composition, which in turn is dependent on the origin and growing conditions. Our study aimed to compare the composition and proregenerative properties of the commercially-available narrow-leaved lavender oil produced in Provence, France, with the oil obtained from the narrow-leaved lavender cultivated locally in Poland. GC/MS analysis showed that self-manufactured essential oil had lower linalool content than commercial oil (23.2 vs. 40.2%), comparable linalyl acetate content (40.6 vs. 44%), while the proportion of lavandulyl acetate was significantly higher (23.2 vs. 5.5%). To determine the influence of lavender oil on the production of proinflammatory cytokines and proregenerative growth factors, gene expression of the selected signaling molecules by HaCaT cells was investigated using real-time PCR. Results showed a concentration-dependent effect of lavender oils on the production of IL-6, IL-8, and VEGF by the keratinocyte cell line. Finally, the potential of the lavender oil to increase the production of VEGF, the most important angiogenic factor, with the in-house preparation performing significantly better in the in vitro cell models was identified.

2 March 2023 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
Małgorzata MiastkowskaMałgorzata Miastkowska
Małgorzata Miastkowska
ESElżbieta Sikora
Elżbieta Sikora
AKAgnieszka Kulawik-Pióro
Agnieszka Kulawik-Pióro
TKTomasz Kantyka
Tomasz Kantyka
EBEwa Bielecka
Ewa Bielecka
ESEmilia Staniszewska-Ślęzak
Emilia Staniszewska-Ślęzak

8 December 2021 in Physiological Reports
Verified
Journal Article
Open access
PDF file
TCTony J. Chen
Tony J. Chen
PMPiotr Mydel
Piotr Mydel
MBMałgorzata Benedyk‐Machaczka
Małgorzata Benedyk‐Machaczka
MKMarta Kamińska
Marta Kamińska
UKUrszula Kałucka
Urszula Kałucka
HMHans‐Peter Marti
Hans‐Peter Marti
AXL tyrosine kinase activation enhances cancer survival and invasiveness, and its overexpression is strongly associated with poor prognosis in advanced renal cell carcinoma. In our preclinical study,...

25 July 2024 in Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
JBJanka Babickova
Janka Babickova
UKUrszula Kałucka
Urszula Kałucka
MKMarta Kaminska
Marta Kaminska
PMPiotr Mydel
Piotr Mydel
ASAlicja Sochaj-Grzegorczyk
Alicja Sochaj-Grzegorczyk
HMHans-Peter Marti
Hans-Peter Marti
Background Chronic kidney disease (CKD) is a progressive, irreversible, and incurable condition characterized by high morbidity and mortality, affecting approximately one-tenth of the global population. Rise of urea-derived cyanate levels in CKD patients, severalfold higher in comparison to those found in healthy individuals, leads to an increased rate of carbamylation of lysine residues of proteins and peptides. This posttranslational modification plays an important role in the progression of kidney failure but also in the onset of CKD-related complications, including previously reported coagulopathies. In this study, we have explored the impact of carbamylation on the functionality of von Willebrand factor (vWF), a pivotal player in hemostasis, and its implications for platelet adhesion. Materials and Methods We have explored carbamylated vWF's interactions with its partner proteins via ELISA. Mass spectrometry was employed to identify modified lysine residues. Blood platelets isolated from healthy donors were carbamylated, and their activation, binding to endothelium and thromboxane release were evaluated using flow cytometry, adhesion assays and ELISA, respectively. Results Using mass spectrometry we detected the vWF's lysine residue smost susceptible to carbamylation. This modification has in turn affected vWF's interactions with its key binding partners: decreased binding to collagen types I/III but increased the affinity to factor FVIII, while its binding to fibrinogen remained unchanged. Carbamylation of vWF impeded vWF-blood platelet binding, but carbamylation of platelets led to their increased thrombin-dependent activation as observed by enhanced phosphatidylserine exposure, improved their binding to vascular endothelium, at the same time decreasing the production of the prothrombotic mediator, thromboxane A2. Conclusion Our findings highlight the multifaceted impact of carbamylation on vWF and platelets, disturbing the delicate balance of coagulation cascade. These alterations could contribute to the complex hemostatic imbalance in ESKD, underscoring the need for further research to fully understand these mechanisms and their clinical implications.